These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1664831)

  • 1. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
    Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
    Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R
    Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
    J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E; Azoulay-Dupuis E; Bauchet J; Pocidalo JJ
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration.
    Varma R; Ahmad AH; Sharma LD; Aggarwal P; Ahuja V
    J Vet Pharmacol Ther; 2003 Aug; 26(4):303-5. PubMed ID: 12887614
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.
    Küng K; Riond JL; Wanner M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):462-8. PubMed ID: 8126763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of pefloxacin and ciprofloxacin into lung tissue.
    Scaglione F; Mezzetti M; Arcidiacono MM; Gattei G; Fraschini F
    J Antimicrob Chemother; 1995 Apr; 35(4):557-9. PubMed ID: 7628993
    [No Abstract]   [Full Text] [Related]  

  • 12. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
    Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():39-44. PubMed ID: 1664828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck.
    Intorre L; Mengozzi G; Bertini S; Bagliacca M; Luchetti E; Soldani G
    Vet Res Commun; 1997 Feb; 21(2):127-36. PubMed ID: 9061885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
    J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves.
    Sharma PK; Ahmad AH; Sharma LD; Varma R
    Vet J; 2003 Jul; 166(1):101-4. PubMed ID: 12788024
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
    Friis C
    Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses.
    Wise R; Honeybourne D
    J Antimicrob Chemother; 1996 May; 37 Suppl A():57-63. PubMed ID: 8737125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
    Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
    J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F
    J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.